Stocktoria

Protalix BioTherapeutics, Inc. PLX

NYSE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2010-09-06 · LEI

Protalix BioTherapeutics, Inc. statistics & valuation

Market cap$189.3M
P / S3.6×
P / B3.9×
Net margin-12.5%
Return on equity-13.7%
FCF margin-25.8%
Return on capital-9.9%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-319.20% -395.90% -77.30% -33.40% -10.40% -71.90% -31.30% 12.70% 5.50% -12.50% 2016201720182019202020212022202320242025
Gross margin (%)
8.70% 19.00% 2016201720182019202020212022202320242025
Operating margin (%)
-360.50% -163.80% -56.40% -19.60% 4.30% -53.40% -27.30% 16.00% 7.30% -10.40% 2016201720182019202020212022202320242025
Return on equity (%)
24.80% 6.80% -13.70% 2016201720182019202020212022202320242025
Shares outstanding
124.1M 143.7M 14.8M 14.8M 34.8M 45.6M 53.8M 82.4M 81.1M 80.4M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-35.70% -115.50% -43.30% -40.30% -9.60% -37.40% -26.80% 9.80% 4.00% -8.00% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-358.20% -52.00% -24.60% -36.50% -42.50% -30.60% -53.80% -3.80% 13.80% -25.80% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$1.23 -$0.22 -$0.62 -$0.31 $0.09 $0.04 -$0.08 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin————————19.0%8.7%
Operating margin-10.4%7.3%16.0%-27.3%-53.4%4.3%-19.6%-56.4%-163.8%-360.5%
Net margin-12.5%5.5%12.7%-31.3%-71.9%-10.4%-33.4%-77.3%-395.9%-319.2%
FCF margin-25.8%13.8%-3.8%-53.8%-30.6%-42.5%-36.5%-24.6%-52.0%-358.2%
Return on assets-8.0%4.0%9.8%-26.8%-37.4%-9.6%-40.3%-43.3%-115.5%-35.7%
Return on equity-13.7%6.8%24.8%140.3%457.0%24.1%26.0%50.0%283.3%294.9%
Current ratio2.512.341.541.381.860.640.812.092.751.09

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.